Henry Ford Health System Receives $16 Million Gift to Benefit Henry Ford Pancreatic Cancer Center
Henry Ford Health System announced a $16 million gift to its Henry Ford Pancreatic Cancer Center (HFPCC), which was launched in 2018 by an initial $20 million gift from the same donor, who wishes to remain anonymous. The gift will bolster the HFPCC’s clinical and translational research endeavors in the fight against this devastating disease.
“We are tremendously thankful for this combined $36 million gift, which not only launched the Henry Ford Pancreatic Cancer Center in 2018, but will further empower our world class clinicians and researchers to continue their pursuit of scientific discoveries that will improve the lives of many affected by this disease,” said Wright Lassiter, III, president and CEO of Henry Ford Health System.
“We are excited to bring together the world’s most innovative minds to accelerate the pace of discovery and understanding,” said David Kwon, M.D., FACS, Clinical Director of the HFPCC. “With such generous funding, we are able to think outside the traditional research paradigms to create a foundational and innovative infrastructure of expert teams that would otherwise not be feasible. This allows us to attract premier scientists and establish collaborations with the world’s best researchers, clinicians, and industry leaders. The goal is to build a center that will continue to foster ground-breaking research in the fight against pancreatic cancer.”
The work of the clinicians, researchers and staff of the HFPCC would not be possible without the generous support of those in the community who want to make a difference in the fight against pancreatic cancer.
To learn more about the HFPCC, visit henryford.com/PancreaticCancer.
To read the full article, visit prnewswire.com
SOURCE Henry Ford Health System